Skip to content

Andersen Group ANDG Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

STU
StubHub Holdings, Inc.STUB
$2.06M
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$126K-60.5%
NTS
Netskope, Inc. Class A Common StockNTSK
$0-100%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$578K
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$0-100%
NNN REIT logo
NNN REITNNN
$100K+17.6%

Other financials

Income statement

See full
Revenue$240.7M+15.7%
Gross profit$74.4M-17.5%
Operating income$24.1M-54.3%
Net income$494.0K-99.0%
EPS (diluted)$0.03

Balance sheet

See full
Cash & equivalents$206.8M+117%
Total debt$448.7M
Total equity-$780.1M
Total assets$608.6M

Cash flow

See full
Operating cash flow-$3.9M-134%
CapEx$3.7M+192%
Free cash flow-$7.6M-176%

Valuation

See full
Market cap$4.2B
Enterprise value$4.44B
P/E68.9×
P/S5.2×

Profitability

See full
Gross margin38.6%+1.4pp
Operating margin19.8%+1.7pp
Net margin20%+1.5pp
FCF margin15.6%-2.7pp

Returns & leverage

See full
Return on equity-13.3%
Debt / equity-0.6×
Current ratio2.4×

Where this comes from

Reported directly by Andersen Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Andersen Group ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Andersen Group 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Andersen Group 's payments of stock issuance costs?
Andersen Group (ANDG) reported payments of stock issuance costs of $1.21M in Q1 2026.
How has Andersen Group 's payments of stock issuance costs changed year-over-year?
Andersen Group 's payments of stock issuance costs increased by 41.1% year-over-year, from $857K to $1.21M.
What does payments of stock issuance costs mean?
Represents the direct cash costs incurred in connection with the issuance of equity, such as underwriting fees, legal, and accounting expenses. High costs relative to proceeds may indicate inefficiencies in the capital raising process.